UroGen Pharma (URGN) Earnings
|
Expand Research on URGN
| Next EPS Date | 8/7/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -14.2% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -1.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/26  |
Q126 | N/A | -$0.46 | N/A | N/A | $45.3M | N/A | N/A | N/A | ||
| 3/2/26 | Q425 | -$0.54 | -$0.48 | -$0.06 | $37.84M | $41.45M | N/A |  | | Details | |
| 11/6/25 | Q325 | -$0.69 | -$0.68 | -$0.01 | $27.48M | $33.19M | N/A | | | Details | |
| 8/7/25 | Q225 | -$1.05 | -$0.83 | -$0.22 | $24.2M | $23.13M | N/A | | | Details | |
| 5/12/25 | Q125 | -$0.92 | -$0.79 | -$0.13 | $20.25M | $22.5M | N/A | | | Details | |
| 3/10/25 | Q424 | -$0.80 | -$0.77 | -$0.03 | $24.56M | $28.24M | N/A | | | Details | |
| 11/6/24 | Q324 | -$0.55 | -$0.82 | +$0.27 | $25.2M | $24.2M | = | | | Details | |
| 8/13/24 | Q224 | -$0.91 | -$0.83 | -$0.08 | $21.8M | $23.97M | = | | | Details |
